APA (7th ed.) Citation

Y, M., Y, I., T, K., H, K., M, I., M, T., . . . T, N. (2008). HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: Preclinical study using mice. International journal of oncology, 32(5), 985.

Chicago Style (17th ed.) Citation

Y, Motomura, et al. "HLA-A2 and -A24-restricted Glypican-3-derived Peptide Vaccine Induces Specific CTLs: Preclinical Study Using Mice." International Journal of Oncology 32, no. 5 (2008): 985.

MLA (9th ed.) Citation

Y, Motomura, et al. "HLA-A2 and -A24-restricted Glypican-3-derived Peptide Vaccine Induces Specific CTLs: Preclinical Study Using Mice." International Journal of Oncology, vol. 32, no. 5, 2008, p. 985.